Surgery Websites
Department of Surgery »  Faculty »  Transplant Surgery  »  Chris E. Freise, M.D.
Chris E. Freise, M.D.

Chris E. Freise, M.D.

  • Professor & Division Chief
  • Division of Transplant Surgery

Contact Information

(415) 353-1888 Clinical, Liver
(415) 353-1551 Clinical, Kidney and Pancreas
(415) 353-9321 Academic
Chris.Freise@ucsf.edu
Open Popup
  • University of Minnesota, B.A., Chemistry, 1978-82
  • University of Minnesota, M.D., 1982-86
  • University of Minnesota, Intern, Surgery, 1986-87
  • University of Minnesota, Resident, Surgery, 1987-89
  • University of Minnesota, Resident, Surgery, 1992-93
  • University of Minnesota, Chief Resident, Surgery, 1993-94
  • University of California, San Francisco, Research Fellow, Surgery, 1989-92
  • University of California, San Francisco, Clinical Fellow, Transplant Surgery, 1994-96
  • American Board of Surgery, 1995
  • Bile Duct Injuries
  • Bile Duct Strictures
  • Cholangiocarcinoma (Bile Duct Cancer)
  • Choledochal Cyst Disease
  • Dialysis Access
  • Expanded Criteria Donor Kidney Transplantation
  • Fulminant Hepatic Failure
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Intestinal Transplantation and Rehabilitation
  • Kidney and LIver Transplantation in HIV Patients
  • Kidney Auto-transplantation
  • Kidney Transplantation
  • Laparoscopic Donor Nephrectomy
  • Laparoscopic Kidney and Liver Surgery
  • Liver Transplantation
  • Living Donor Kidney Transplantation
  • Living Donor Liver Transplantation
  • Pancreas Transplantation
  • Pediatric Kidney Transplantation
  • Pediatric Liver Transplantation
  • Polycystic Kidney Disease
  • Polycystic Liver Disease
  • Portal Hypertension
  • Surgical Shunts
  • Delivery of Immunosuppressive Agents to Organ Allografts
  • Improvement Organ Function in Deceased Donors
  • Ischemia Reperfusion Injury

Chris E. Freise, M.D. received his medical degree from the University of Minnesota where he also did his internship and residency in General Surgery. He later completed a  transplantation fellowship at UCSF.   

He is a member of numerous professional organizations including The Transplantation Society, the International Pancreas and Islet Transplant Association, the Transplant Infectious Disease Society, the American Hepato-Pancreato-Billiary Association and the Society of University Surgeons. In addition, he recently served as the Medical Director for California Transplant Donor Network. He is also the Associate Counselor for UNOS Region 5, and a member of the UNOS Membership and Professional Standards Committee.

Dr. Freise has authored more than eighty (80) in peer-reviewed publications and five (5) book chapters. He is an accomplished researcher and clinical educator. Dr. Freise is also a frequent invited lecturer to national and international and conferences in the field.         

Dr. Friese's basic science research focuses on the delivery of immunosuppressive agents to organ allografts, ischemia reperfusion injury, and methods to improve organ function in deceased donors. His clinical research includes  a multicenter trial investigating donor and recipient outcomes following living donor liver transplantation.

Data provided by UCSF Profiles, powered by CTSI
  • Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients
    Sponsor:
    Sponsor ID:
    Funding Period:
    Feb 2010
    -
    Aug 2015
    Principal Investigator
  • Living Donor Liver Transplant :Short &Long-Term Impact on Donors and Recipients
    Sponsor:
    Sponsor ID:
    Funding Period:
    Sep 2002
    -
    Aug 2015
    Principal Investigator
MOST RECENT PUBLICATIONS FROM A TOTAL OF 123
Data provided by UCSF Profiles, powered by CTSI
  1. Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation. Front Surg. 2021; 8:808733. View in PubMed
  2. Chipman V, Cooper M, Thomas AG, Ronin M, Lee B, Flechner S, Leeser D, Segev DL, Mandelbrot DA, Lunow-Luke T, Syed S, Hil G, Freise CE, Waterman AD, Roll GR. Motivations and outcomes of compatible living donor-recipient pairs in paired exchange. Am J Transplant. 2022 01; 22(1):266-273. View in PubMed
  3. Thiessen C, Arslan G, Roberts J, Freise C. Biliary obstruction following ureteral revision of a transplanted kidney. Am J Transplant. 2021 04; 21(4):1657-1659. View in PubMed
  4. Wisel SA, Thiessen C, Day R, Belin LJ, Syed SM, Hirose R, Ascher N, Roberts JP, Freise CE. Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement". Am J Transplant. 2021 05; 21(5):1981-1982. View in PubMed
  5. Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL. Opioid use prior to liver transplant is associated with increased risk of death after transplant. Am J Surg. 2021 07; 222(1):234-240. View in PubMed
  6. View All Publications

 

Site Directory
    X